Participants 44 92 4
in patients insufficiently controlled on timolol
Participants 230 341 4
in patients with open angle glaucoma or ocular hypertension where IOP is not adequately controlled with timolol
Participants 416 569 8
53 patients with primary open angle glaucoma, capsular glaucoma, or ocular hypertension with an IOP of at least 21 mmHg on current therapy were recruited
Participants 695 855 3
One group continued on timolol, one switched from timolol to latanoprost, 50 microg/ml once daily, and a third group received latanoprost in addition to timolol
